This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Why Skyward (SKWD) is Poised to Beat Earnings Estimates Again
by Zacks Equity Research
Skyward (SKWD) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Skyward (SKWD) Upgraded to Buy: Here's Why
by Zacks Equity Research
Skyward (SKWD) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
SKWD vs. KNSL: Which Stock Is the Better Value Option?
by Zacks Equity Research
SKWD vs. KNSL: Which Stock Is the Better Value Option?
These 2 Finance Stocks Could Beat Earnings: Why They Should Be on Your Radar
by Zacks Equity Research
Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.
SKWD vs. PGR: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
SKWD vs. PGR: Which Stock Is the Better Value Option?
Root, Inc. (ROOT) Hits Fresh High: Is There Still Room to Run?
by Zacks Equity Research
Root (ROOT) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Skyward (SKWD) Reports Q4 Earnings: What Key Metrics Have to Say
by Zacks Equity Research
The headline numbers for Skyward (SKWD) give insight into how the company performed in the quarter ended December 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Skyward Specialty Insurance (SKWD) Q4 Earnings and Revenues Top Estimates
by Zacks Equity Research
Skyward (SKWD) delivered earnings and revenue surprises of 3.90% and 1.50%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?
Why Skyward (SKWD) Could Beat Earnings Estimates Again
by Zacks Equity Research
Skyward (SKWD) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Insights Into Skyward (SKWD) Q4: Wall Street Projections for Key Metrics
by Zacks Equity Research
Get a deeper insight into the potential performance of Skyward (SKWD) for the quarter ended December 2024 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.
Why Investors Need to Take Advantage of These 2 Finance Stocks Now
by Zacks Equity Research
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
Palomar (PLMR) Surpasses Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Palomar (PLMR) delivered earnings and revenue surprises of 22.58% and 6.62%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?
CNA Financial (CNA) Q4 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
CNA Financial (CNA) delivered earnings and revenue surprises of 12.61% and 4.58%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?
Skyward (SKWD) Upgraded to Buy: Here's What You Should Know
by Zacks Equity Research
Skyward (SKWD) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Skyward Specialty Insurance (SKWD) Just Overtook the 50-Day Moving Average
by Zacks Equity Research
When a stock breaks out above the 50-Day simple moving average, good things could be on the horizon. How should investors react?
SKWD Stock Trades Below 50-Day SMA: What Should Investors Do Now?
by Tanuka De
SKWD's focus on high-return areas, prudent pricing, better retention and shifting of the business mix toward more profitable lines makes it poised for growth.
All You Need to Know About Skyward (SKWD) Rating Upgrade to Buy
by Zacks Equity Research
Skyward (SKWD) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Skyward Specialty Trading at a Premium: How Should You Play the Stock?
by Zacks Equity Research
Focus on high-return areas, prudent pricing, better retention and shifting of the business mix toward more profitable lines poise SKWD for growth.
Skyward Specialty Stock Gains 48% YTD: Time to Buy or Hold?
by Zacks Equity Research
Improving top line, expanding margins and sufficient financial flexibility continue to drive SKWD.
Skyward Specialty Insurance Group, Inc. (SKWD) Soars to 52-Week High, Time to Cash Out?
by Zacks Equity Research
Skyward (SKWD) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Root, Inc. (ROOT) Hit a 52 Week High, Can the Run Continue?
by Zacks Equity Research
Root (ROOT) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
SKWD or KNSL: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
SKWD vs. KNSL: Which Stock Is the Better Value Option?
Skyward (SKWD) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
by Zacks Equity Research
Although the revenue and EPS for Skyward (SKWD) give a sense of how its business performed in the quarter ended September 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Skyward Specialty Insurance (SKWD) Tops Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Skyward (SKWD) delivered earnings and revenue surprises of 10.94% and 2.89%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
What's in Store for These 3 Insurance Stocks in Q3 Earnings?
by Sushmita Sarker
Here, we take a look at three insurance stocks, UNM, CB and SKWD, which are set to report third-quarter earnings on Oct. 29.